Loading...

LivaNova PLC

LIVNNASDAQ
Healthcare
Medical - Devices
$64.20
$-0.94(-1.45%)
U.S. Market opens in 30h 27m

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E Ratio-14.41
EPS (TTM)$-4.45
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$63.05
3 Months$71.02
1 Year Target$57.97

LIVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LivaNova PLC (LIVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.41 and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.45%
5-Day Change
-2.70%
1-Month Change
2.88%
3-Month Change
1.65%
6-Month Change
16.96%
Year-to-Date (YTD) Change
4.34%
1-Year Change
72.30%
3-Year Change
31.64%
5-Year Change
-22.17%
All-Time (Max) Change
-8.19%

Contact Information

44 20 3325 0660
20 Eastbourne Terrace, London, NaN, W2 6LG

Company Facts

2,900 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions